Skip to main content
SpringerLink
Log in

Medical Oncology

  • Chapter
Concise Manual of Hematology and Oncology

  • 2354 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 159.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 209.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bernier J, Domenge C, Ozsahin M et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004;350:1945–52

    PubMed  CAS  Google Scholar 

  2. Bonner JA, Harari PM, Giralt J et al. Radiotherapy plus cetuximab for squamous cell carcinoma of the head and neck. N Engl J Med 2006;354:567–78

    PubMed  CAS  Google Scholar 

  3. Colevas AD. Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck. J Clin Oncol 2006;24:2644–52

    PubMed  CAS  Google Scholar 

  4. Cooper JS, Pajak TF, Forastiere AA et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous cell carcinoma of the head and neck. N Engl J Med 2004;350:1937–44

    PubMed  Google Scholar 

  5. ESMO Guidelines Working Group. Squamous cell carcinoma of the head and neck: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol 2007;18(Suppl 2):ii65–6

    Google Scholar 

  6. Le Tourneau C, Faivre A, Siu LL. Molecular targeted therapy of head and neck cancer: Review and clinical development challenges. Eur J Cancer 2007;43:2457–66

    PubMed  Google Scholar 

  7. Posner MR, Hershock DM, Blajman CR et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 2007;357:1705–15

    PubMed  CAS  Google Scholar 

  8. Salama JK, Seiwert TY, Vokes EE. Chemoradiotherapy for locally advanced head and neck cancer. J Clin Oncol 2007;25:4118–26

    PubMed  CAS  Google Scholar 

  9. Seiwert TY, Cohen EEW. State-of-the-art management of locally advanced head and neck cancer. Br J Cancer 2005;92:1341–8

    PubMed  CAS  Google Scholar 

  10. http://www.nlm.nih.gov/medlineplus/headandneckcancer.html Medline Plus

    Google Scholar 

  11. http://www.cochrane-ent.org Cochrane HNO

    Google Scholar 

  12. http://www.cancer.gov/cancertopics/types/head-and-neck NCI, Cancertopics

    Google Scholar 

  13. http://www.cancerbackup.org.uk/Cancertype/Headneck Cancer BACKUP

    Google Scholar 

  14. http://www.emedicine.com/plastic/topic376.htm E-medicine

    Google Scholar 

  15. Blackstock AW, Govindan R. Definitive chemoradiation for the treatment of locally advanced NSCLC. J Clin Oncol 2007;25:4146–52

    PubMed  CAS  Google Scholar 

  16. ESMO Guidelines Working Group. NSCLC: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol 2007;18(suppl 2):ii30–1

    Google Scholar 

  17. ESMO Guidelines Working Group. SCLC: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol 2007;18(Suppl.2):ii32–3

    Google Scholar 

  18. Jackman DM, Johnson BE. Small-cell lung cancer. Lancet 2005;366:1385–96

    PubMed  CAS  Google Scholar 

  19. Lally BE, Urbanic JJ, Blackstock AW et al. SCLC: have we made any progress over the last 25 years? Oncologist 2007;12:1096–104

    PubMed  Google Scholar 

  20. Pfister DG, Johnson DH, Azzoli CG et al. ASCO treatment of unresectable non-small-cell lung cancer guideline: Update 2003. J Clin Oncol 2004;22:330–53

    PubMed  Google Scholar 

  21. Pfister KMW, Evans WK, Azzoli CG et al. Cancer Care Ontario and ASCO adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable NSCLC Guideline. J Clin Oncol 2007;25:5506–18

    Google Scholar 

  22. Ramalingam S, Belani C. Systemic chemotherapy for advanced NSCLC: recent advances and future directions. Oncologist 2008;13:5–13

    PubMed  CAS  Google Scholar 

  23. Sandler A, Gray R, Perry MC et al. Paclitaxel-carboplatin alone or with bevacizumab for NSCLC. N Engl J Med 2006;355:2542–50

    PubMed  CAS  Google Scholar 

  24. http://www.nlm.nih.gov/medlineplus/lungcancer.html MedlinePlus

    Google Scholar 

  25. http://www.cancer.gov/cancertopics/types/lung NCI, CancerNet

    Google Scholar 

  26. http://www.emedicine.com/med/topic1333.htm E-medicine

    Google Scholar 

  27. http://www.lungcanceronline.org/ Lung Cancer Online

    Google Scholar 

  28. http://www.lungcancer.org/ Lung Cancer Focus

    Google Scholar 

  29. Bofetta P. Epidemiology of peritoneal mesothelioma: a review. Ann Oncol 2007;18:985–90

    Google Scholar 

  30. Ceresoli GL, Betta GP, Castagneto B et al. Malignant pleural mesothelioma. Ann Oncol 2006;17(suppl 2):ii13–6

    PubMed  Google Scholar 

  31. ESMO Guidelines Working Group. Malignant pleural mesothelioma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol 2007;18(Suppl. 2):ii34–5

    Google Scholar 

  32. Hassan R, Alexander R, Antman K et al. Current treatment options and biology of peritoneal mesothelioma. Ann Oncol 2006;17:1615–9

    PubMed  CAS  Google Scholar 

  33. Robinson BWS, Lake RA. Advances in malignant mesothelioma. N Engl J Med 2005;353:1591–603

    PubMed  CAS  Google Scholar 

  34. Vogelzang NJ, Rusthoven JJ, Symanowski J et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003;21:2636–44

    PubMed  CAS  Google Scholar 

  35. Zucali PA, Giaccone G. Biology and management of malignant pleural mesothelioma. Eur J Cancer 2006;42:2706–14

    PubMed  CAS  Google Scholar 

  36. http://www.cancer.gov/cancertopics/types/malignantmesothelioma NCI, Cancer Topics

    Google Scholar 

  37. http://www.emedicine.com/MED/topic1457.htm E-medicine

    Google Scholar 

  38. http://www.mesolink.org Mesothelioma Info

    Google Scholar 

  39. http://www.mesotheliomanews.com Mesothelioma News

    Google Scholar 

  40. De Jong WK, Blaauwgeers JLG, Schaapveld M et al. Thymic epithelial tumors: A population-based study of the incidence, diagnostic procedures and therapy. Eur J Cancer 2008;44:123–30

    PubMed  Google Scholar 

  41. Giaccone G. Treatment of malignant thymoma. Curr Opin Oncol 2005;17:140–6

    PubMed  Google Scholar 

  42. Riedel RF, Burfeind WR. Thymoma: benign appearance, malignant potential. Oncologist 2006;11:887–94

    PubMed  Google Scholar 

  43. http://www.cancer.gov/cancertopics/types/thymoma/ NCI, Cancer Topics

    Google Scholar 

  44. http://www.emedicine.com/med/topic2752.htm E-medicine

    Google Scholar 

  45. http://www.acor.org/cnet/62708.html ACOR

    Google Scholar 

  46. Cunningham D, Starling N, Rao S et al. Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med 2008;358:36–46

    PubMed  CAS  Google Scholar 

  47. ESMO Guidelines Working Group. Esophageal cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol 2007;18(Suppl. 2):ii15–6

    Google Scholar 

  48. Heitmiller RF. Epidemiology, diagnosis, and staging of esophageal cancer. Cancer Treat Res 2001;105:375–86

    PubMed  CAS  Google Scholar 

  49. Kleinberg L, Forastiere AA. Chemoradiation in the management of esophageal cancer. J Clin Oncol 2007;25:4110–7

    PubMed  CAS  Google Scholar 

  50. Koshy M, Esiashvilli N, Landry JC et al. Multiple management modalities in esophageal cancer: epidemiology, presentation and progression, work-up, and surgical approaches. Oncologist 2004;9:137–46

    PubMed  Google Scholar 

  51. MRC Oesophageal Cancer Working Party. Surgical resection with or without chemotherapy in oesophageal cancer. Lancet 2002;359:1727–33

    Google Scholar 

  52. Souza RF, Spechler SJ. Concepts in the prevention of adenocarcinoma of the distal esophagus and proximal stomach. CA Cancer J Clin 2005;55:334–51

    PubMed  Google Scholar 

  53. Tew WP, Kelsen DP, Ilson DH. Targeted therapies for esophageal cancer. Oncologist 2005;10:590–601

    PubMed  CAS  Google Scholar 

  54. Van Meerten E, Van der Gaast A. Systemic treatment for oesophageal cancer. Eur J Cancer 2005;41:664–72

    PubMed  Google Scholar 

  55. http://www.nlm.nih.gov/medlineplus/esophagealcancer.html Medline Plus

    Google Scholar 

  56. http://www.cancer.gov/cancertopics/types/esophageal/ NCI, Cancer Topics

    Google Scholar 

  57. http://www.emedicine.com/MED/topic741.htm E-medicine

    Google Scholar 

  58. http://www.cancerbackup.org.uk/Cancertype/Gulletoesophagus Cancer BACKUP

    Google Scholar 

  59. http://www.cancerlinksusa.com/esophageal.htm Cancerlinks

    Google Scholar 

  60. Ajani JA. Evolving chemotherapy for gastric cancer. Oncologist 2005;10(Suppl. 3):49–58

    PubMed  CAS  Google Scholar 

  61. Cunningham D, Allum WH, Stenning SP et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006;355:11–20

    PubMed  CAS  Google Scholar 

  62. De Vita F, Giuliani F, Galzia G. et al. Neo-adjuvant and adjuvant chemotherapy of gastric cancer. Ann Oncol 2007;18(Suppl. 6):vi120–3

    PubMed  Google Scholar 

  63. ESMO Guidelines Working Party. Gastric cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol 2007;18(Suppl. 2):ii17–8

    Google Scholar 

  64. Hejna M, Wöhrer S, Schmidinger M et al. Postoperative chemotherapy for gastric cancer. Oncologist 2006;11:136–45

    PubMed  CAS  Google Scholar 

  65. Jansen EPM, Boot H, Verheij M et al. Optimal locoregional treatment in gastric cancer. J Clin Oncol 2005;20:4509–17

    Google Scholar 

  66. Lim L, Michael M, Mann GB et al. Adjuvant therapy in gastric cancer. J Clin Oncol 2005;23:6220–32

    PubMed  CAS  Google Scholar 

  67. Matysiak-Budnik T, Mégraud F. Helicobacter pylori infection and gastric cancer. Eur J Cancer 2006;42:708–16

    PubMed  CAS  Google Scholar 

  68. Tabernero J, Macarulla T, Ramos FJ et al. Novel targeted therapies in the treatment of gastric and esophagus cancer. Ann Oncol 2005;16:1740–8

    PubMed  CAS  Google Scholar 

  69. http://www.nlm.nih.gov/medlineplus/stomachcancer.html Medline Plus

    Google Scholar 

  70. http://www.cancer.gov/cancertopics/types/stomach/ NCI, Cancer Topics

    Google Scholar 

  71. http://www.emedicine.com/MED/topic845.htm E-medicine

    Google Scholar 

  72. http://www.medicinenet.com/stomach_cancer/article.htm Medicine Net

    Google Scholar 

  73. Barnes G, Romero L, Hess KR et al. Primary adenocarcinoma of the duodenum: management and survival in 67 patients. Ann Surg Oncol 1994;1:73–7

    PubMed  Google Scholar 

  74. Delaunoit T, Neczyporenko F, Limburg PJ et al. Pathogenesis and risk factors of small bowel adenocarcinoma: a colorectal cancer sibling? Am J Gastroenterol 2005;100:703–10

    PubMed  Google Scholar 

  75. North JH, Pack MS. Malignant tumors of the small intestine: a review of 144 cases. Am J Surg 2000;66:46–51

    CAS  Google Scholar 

  76. Stang A, Stegmaier C, Eisinger B et al. Descriptive epidemiology of small intestinal malignancies: the German Cancer Registry experience. Br J Cancer 1999;80:1440–4

    PubMed  CAS  Google Scholar 

  77. Wheeler JMD, Warren BF, Mortensen NJ et al. An insight into the genetic pathway of the small intestine. Gut 2002;50:218–23

    PubMed  CAS  Google Scholar 

  78. http://www.cancer.gov/cancertopics/pdq/treatment/
smallintestine/healthprofessional/ NCI Cancer Topics

    Google Scholar 

  79. http://www.emedicine.com/med/topic2652.htm E-medicine

    Google Scholar 

  80. http://www.csmc.edu/pf_5626.html Cedars Sinai

    Google Scholar 

  81. http://www.thedoctorsdoctor.com/diseases/
small_bowel_adenocarcinoma.htm Doctor’s Doctor

    Google Scholar 

  82. http://gastroresource.com/gitextbook/en/Chapter7/7-24.htm Gastroenterology Resource

    Google Scholar 

  83. Benson AB, Schrag D, Somerfield MR et al. ASCO recommendations on adjuvant chemotherapy or stage II colon cancer. J Clin Oncol 2004;22:3408–19

    PubMed  Google Scholar 

  84. Board RE, Valle J. Metastatic colorectal cancer. Drugs 2007;67:1851–67

    PubMed  CAS  Google Scholar 

  85. Desch CE, Benson AB, Somerfield MR et al. Colorectal cancer surveillance: 2005 update of an ASCO Practice Guideline. J Clin Oncol 2005;23:8512–9

    PubMed  Google Scholar 

  86. ESMO Guidelines Working Group. Colon cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol 2007;18(suppl 2):ii21–2

    Google Scholar 

  87. ESMO Guidelines Working Group. Rectal cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol 2007;18(suppl 2):ii23–4

    Google Scholar 

  88. ESMO Guidelines Working Group. Advanced colorectal cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol 2007;18(suppl 2):ii25–6

    Google Scholar 

  89. Jackson C, Cunningham D. Where to position monoclonal antibodies in first-line treatment of advanced colorectal cancer. Eur J Cancer 2008;44:652–62

    PubMed  CAS  Google Scholar 

  90. Meyerhardt JA, Mayer RJ. Systemic therapy for colorectal cancer. N Engl J Med 2005;352:476–87

    PubMed  CAS  Google Scholar 

  91. Wolpin BM, Meyerhardt JA, Mamon HJ et al. Adjuvant treatment of colorectal cancer. CA Cancer J Clin 2007;57:168–85

    PubMed  Google Scholar 

  92. http://www.nlm.nih.gov/medlineplus/colorectalcancer.html MedlinePlus

    Google Scholar 

  93. http://cancernet.nci.nih.gov/cancertopics/types/colon-and-rectal NCI Cancernet

    Google Scholar 

  94. http://www.emedicine.com/med/topic413.htm E-medicine

    Google Scholar 

  95. http://www.emedicine.com/med/topic1994.htm E-medicine

    Google Scholar 

  96. http://www.nccn.org/professionals/physician_gls/PDF/colon.pdf NCCN Guideline

    Google Scholar 

  97. http://www.nccn.org/professionals/physician_gls/PDF/rectal.pdf NCCN Guideline

    Google Scholar 

  98. Clark MA, Hartley A, Geh JI. Cancer of the anal canal. Lancet Oncol 2004;5:149–57

    PubMed  Google Scholar 

  99. Einstein MH, Kadish AS. Anogenital neoplasia in AIDS. Curr Opin Oncol 2004;16:455–62

    PubMed  Google Scholar 

  100. Rousseau DL, Thomas CR, Petrelli NJ et al. Squamous cell carcinoma of the anal canal. Surg Oncol 2005;14:121–32

    PubMed  Google Scholar 

  101. Steinbrook R. The potential of human papillomavirus vaccines. N Engl J Med 2006;354:1109–12

    PubMed  CAS  Google Scholar 

  102. Uronis HE, Bendell JC. Anal Cancer. Oncologist 2007;12:524–34

    PubMed  Google Scholar 

  103. http://www.nlm.nih.gov/medlineplus/analcancer.html MedlinePlus

    Google Scholar 

  104. http://www.nccn.org/professionals/physician_gls/PDF/anal.pdf NCCN Guideline

    Google Scholar 

  105. Cardenes Hr, Chiorean EG, De Witt J et al. Locally advanced pancreatic cancer. Oncologist 2006;11:612–23

    PubMed  CAS  Google Scholar 

  106. Chua YJ, Cunningham D. Adjuvant treatment for resectable pancreatic cancer. J Clin Oncol 2005;23:4532–7

    PubMed  CAS  Google Scholar 

  107. ESMO Guidelines Working Group. Pancreatic cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol 2007;18(Suppl. 2):ii19–20

    Google Scholar 

  108. Neoptolemos JP, Stocken DD, Friess H et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004;350:1200–10

    PubMed  CAS  Google Scholar 

  109. Sultana A, Tudur Smith C, Cunningham D et al. Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer. J Clin Oncol 2007;25:2607–15

    PubMed  Google Scholar 

  110. Verslype C, Van Cutsem E, Dicato M et al. The management of pancreatic cancer. Ann Oncol 2007;18(Suppl. 7):vii1–vii10

    PubMed  Google Scholar 

  111. Willett CG, Czito BG, Bendell JC et al. Locally advanced pancreatic cancer. J Clin Oncol 2005;23:4538–44

    PubMed  Google Scholar 

  112. Yang GY, Wagner TD, Fuss M et al. Multimodality approaches for pancreatic cancer. CA Cancer J Clin 2005;55:352–67

    PubMed  Google Scholar 

  113. http://www.nlm.nih.gov/medlineplus/pancreaticcancer.html MedlinePlus

    Google Scholar 

  114. http://www.emedicine.com/MED/topic1712.htm E-medicine

    Google Scholar 

  115. http://www.cancer.org/docroot/CRI/CRI_2_3x.asp?dt=34 Am Cancer Soc

    Google Scholar 

  116. http://www.path.jhu.edu/pancreas Johns Hopkins Univ

    Google Scholar 

  117. Blum HE. Hepatocellular carcinoma: therapy and prevention. World J Gastroenterol 2005;11:7391–400

    PubMed  CAS  Google Scholar 

  118. Greten TF, Papendorf F, Bleck JS et al. Survival rate in patients with hepatocellular carcinoma. Br J Cancer 2005;92:1862–8

    PubMed  CAS  Google Scholar 

  119. Hertl M, Cosimi AB. Liver transplantation for malignancy. Oncologist 2004;10:269–81

    Google Scholar 

  120. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003;362:1907–17

    PubMed  Google Scholar 

  121. Mann CD, Neal CP, Garcea G et al. Prognostic molecular markers in hepatocellular carcinoma. Eur J Cancer 2007;43:979–92

    PubMed  CAS  Google Scholar 

  122. Nowak AK, Chow PKH, Findlay M. Systemic therapy for advanced hepatocellular carcinoma. Eur J Cancer 2004;40:1474–84

    PubMed  CAS  Google Scholar 

  123. Zhu AX. Systematic therapy of advanced hepatocellular carcinoma: how hopeful should we be? Oncologist 2006;11:790–800

    PubMed  CAS  Google Scholar 

  124. http://www.nlm.nih.gov/medlineplus/livercancer.html MedlinePlus

    Google Scholar 

  125. http://www.emedicine.com/MED/topic2664.htm E-medicine

    Google Scholar 

  126. http://www.livercancer.com/ Liver Cancer Network

    Google Scholar 

  127. http://www.livertumor.org/ Liver Tumor Portal

    Google Scholar 

  128. http://www.cnn.com/HEALTH/library/DS/00399.html CNN Health

    Google Scholar 

  129. Anderson CD, Pinson CW, Berlin J et al. Diagnosis and treatment of cholangiocarcinoma. Oncologist 2004;9:43–57

    PubMed  Google Scholar 

  130. Brugge WR. Endoscopic techniques to diagnose and manage biliary tumors. J Clin Oncol 2005;23:4561–5

    PubMed  Google Scholar 

  131. De Groen PC, Gores GJ, LaRusso NF et al. Biliary tract cancers. N Engl J Med 1999;341:1368–78

    PubMed  Google Scholar 

  132. Khan SA, Thomas HC, Davidson BR et al. Cholangiocarcinoma. Lancet 2005;366:1303–14

    PubMed  Google Scholar 

  133. Patel T. Cholangiocarcinoma. Nat Clin Pract Gastroenterol Hepatol 2006;3:33–42

    PubMed  Google Scholar 

  134. Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographic distribution and risk factors. Int J Cancer 2006;118:1591–602

    PubMed  CAS  Google Scholar 

  135. Wistuba II, Gazdar AF. Gallbladder cancer: lessons from a rare tumor. Nature Rev Cancer 2004;4:695–706

    CAS  Google Scholar 

  136. http://www.cancer.gov/cancertopics/types/gallbladder Cancer Topics

    Google Scholar 

  137. http://www.nlm.nih.gov/medlineplus/ency/article/000291.htm Medline Plus

    Google Scholar 

  138. http://www.emedicine.com/med/topic343.htm E-medicine

    Google Scholar 

  139. http://www.nccn.org/professionals/physian_gls/PDF/hepatobiliary.pdf NCCN Guideline

    Google Scholar 

  140. Beslija S, Bonneterre J, Burstein H et al. Second consensus on medical treatment of metastatic breast cancer. Ann Oncol 2007;18:215–25

    PubMed  CAS  Google Scholar 

  141. Cinierie S, Orlando L, Fedele P et al. Adjuvant strategies in breast cancer: new prospectives, questions and reflections at the end of 2007 St Gallen International Expert Consensus Conference. Ann Oncol 2007;18(Suppl. 6):vi63–5

    Google Scholar 

  142. ESMO Guidelines Working Group. Primary breast cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol 2007;18(Suppl. 2):ii5–8

    Google Scholar 

  143. ESMO Guidelines Working Group. Recurrent or metastatic breast cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol 2007;18(Suppl. 2):ii9–11

    Google Scholar 

  144. Goldhirsch A, Wood WC, Gelber RD et al. Progress and promise: highlights of the international expert consensus on the pimary therapy of early breast cancer 2007. Ann Oncol 2007;18:1133–44

    PubMed  CAS  Google Scholar 

  145. Kaufmann M, von Minckwitz G, Bear HD et al. Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006. Ann Oncol 2007;18:1927–34

    PubMed  CAS  Google Scholar 

  146. Khatcheressian JL, Wolff AC, Smith TJ et al. ASCO 2006 update of the breast follow-up and management guidelines in the adjuvant setting. J Clin Oncol 2007;24:5091–7

    Google Scholar 

  147. Perry N, Broeders M, De Wolf C et al. European guidelines for quality assurance in breast cancer screening and diagnosis. Ann Oncol 2008;19:614–22

    PubMed  CAS  Google Scholar 

  148. Von Minckwitz G. Evidence-based treatment of metastatic breast cancer – 2006 recommendations by the AGO Breast Commission. Eur J Cancer 2006;42:2897–908

    PubMed  Google Scholar 

  149. http://www.cancer.gov/cancerinfo/types/breast NCI Cancer Topics

    Google Scholar 

  150. http://www.nlm.nih.gov/medlineplus/breastcancer.html MedlinePlus

    Google Scholar 

  151. http://www.nccn.org/professionals/physician_gls/PDF/breast.pdf NCCN Guideline

    Google Scholar 

  152. http://www.emedicine.com/med/topic2808.htm E-medicine

    Google Scholar 

  153. Cadron I, Leunen K, Van Gorp T et al. Management of borderline ovarian neoplasms. J Clin Oncol 2007;25:2928–37

    PubMed  Google Scholar 

  154. Cannistra SA. Cancer of the ovary. N Engl J Med 2004;351:2519–29

    PubMed  CAS  Google Scholar 

  155. Collaborative Group on Epidemiological Studies of Ovarian Cancer. Ovarian cancer and oral contraceptives. Lancet 2008;317:303–14

    Google Scholar 

  156. DuBois A, Quinn M, Thigpen T et al. 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference. Ann Oncol 2005;16(suppl 8):viii7–12

    Google Scholar 

  157. ESMO Guideline Working Group. Epithelial ovarian carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol 2007;18(suppl 2):ii12–4

    Google Scholar 

  158. Rao G, Crispens M, Rothenberg ML. Intraperitoneal chemotherapy for ovarian cancer: overview and perspective. J Clin Oncol 2007;25:2867–72

    PubMed  CAS  Google Scholar 

  159. Rose PG, Nerenstone S, Brady MF et al. Secondary surgical cytoreduction for advanced ovarian carcinoma. N Engl J Med 2004;351:2489–97

    PubMed  CAS  Google Scholar 

  160. http://www.cancer.gov/cancertopics/types/ovarian/ NCI Cancer Topics

    Google Scholar 

  161. http://www.nlm.nih.gov/medlineplus/ovariancancer.html MedlinePlus

    Google Scholar 

  162. http://www.nccn.org/professionals/physician_gls/PDF/ovarian.pdf NCCN Guideline

    Google Scholar 

  163. http://www.emedicine.com/med/topic1698.htm E-medicine

    Google Scholar 

  164. http://www.cnn.com/HEALTH/library/DS/00293.html CNN Health

    Google Scholar 

  165. Gershenson DM. Management of ovarian germ cell tumors. J Clin Oncol 2007;25:2938–43

    PubMed  CAS  Google Scholar 

  166. Lai CH, Chang TC, Hsueh S et al. Outcome and prognostic factors in ovarian germ cell malignancies. Gynecol Oncol 2005;96:784–91

    PubMed  Google Scholar 

  167. Lu KH, Gershenson DM. Update on the management of ovarian germ cell tumors. J Reprod Med 2005;50:417–25

    PubMed  Google Scholar 

  168. Schmoll HJ, Souchon R, Krege S et al. European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 2004;15:1377–99

    PubMed  CAS  Google Scholar 

  169. Zanetta G, Bonazzi C, Cantu M et al. Survival and reproductive function after treatment of malignant germ cell ovarian tumors. J Clin Oncol 2001;19:1015–20

    PubMed  CAS  Google Scholar 

  170. http://www.cancer.gov/cancertopics/pdq/treatment/
ovarian-germ-cell/HealthProfessional NCI Cancer Topics

    Google Scholar 

  171. http://www.emedicine.com/med/topic601.htm E-medicine

    Google Scholar 

  172. Colombo N, Parma G, Zanagnolo V et al. Management of ovarian stromal tumors. J Clin Oncol 2007;25:2944–51

    PubMed  CAS  Google Scholar 

  173. Schumer ST, Cannistra SA. Granulosa cell tumor of the ovary. J Clin Oncol 2003;21:1180–9

    PubMed  Google Scholar 

  174. Uygun K, Aydiner A, Saip P et al. Clinical parameters and treatment results in recurrent granulosa cell tumor of the ovary. Gynecol Oncol 2003;88:400–3

    PubMed  Google Scholar 

  175. http://www.emedicine.com/med/topic928.htm E-medicine

    Google Scholar 

  176. Gheorghisan-Galateanu A, Fica S, Terzea DC et al. Sertoli-Leydig cell tumor: a rare androgen-secreting ovarian tumor in postmenopausal women. J Cell Mol Med 2003;7:461–71

    PubMed  Google Scholar 

  177. Schneider DT, Calaminus G, Wessalowksi R et al. Ovarian sex cord-stromal tumors in children and adolescents. J Clin Oncol 2003;12:2357–63

    Google Scholar 

  178. Young RH, Scully RE. Ovarian Sertoli-Leydig cell tumors. A clinicopathological analysis of 207 cases. Am J Surg Pathol 1985;8:543–69

    Google Scholar 

  179. http://www.nccn.org/ NCCN Guidelines

    Google Scholar 

  180. Altieri A, Franceschi S, Ferlay J et al. Epidemiology and aetiology of gestational trophoblastic diseases. Lancet Oncol 2003;4:670–8

    PubMed  Google Scholar 

  181. Carney ME. Treatment of low risk gestational trophoblastic disease. Clin Obstet Gynecol 2003;46:579–92

    PubMed  Google Scholar 

  182. Dainty LA, Winter WE, Maxwell GL. The clinical behavior of placental site trophoblastic tumor and contemporary methods of management. Clin Obstet Gynecol 2003;46:607–11

    PubMed  Google Scholar 

  183. Ngan HY, Bender H, Benedet JL et al. Gestational trophoblastic neoplasia, FIGO 2000 staging and classification. Int J Gynaecol Obstet 2003;83(suppl 1):175–7

    PubMed  Google Scholar 

  184. Smith HO, Kohorn E, Cole LA. Choriocarcinoma and gestational trophoblastic disease. Obstet Gynecol Clin North Am 2005;32:661–84

    PubMed  Google Scholar 

  185. Soper JT, Mutch DG, Schink JC et al. Diagnosis and treatment of gestational trophoblastic disease: ACOG Practice Bulletin No. 53. Gynecol Oncol 2004;93:575–85

    PubMed  Google Scholar 

  186. Wright JD, Mutch DG. Treatment of high-risk gestational trophoblastic tumors. Clin Obstet Gynecol 2003;46:593–606

    PubMed  Google Scholar 

  187. http://www.nlm.nih.gov/medlineplus/ency/article/001496.htm MedlinePlus

    Google Scholar 

  188. http://www.emedicine.com/MED/topic866.htm E-medicine

    Google Scholar 

  189. http://cancerweb.ncl.ac.uk/cancernet/201163.html CancerWeb

    Google Scholar 

  190. http://www.fpnotebook.com/OB65.htm FP Notebook

    Google Scholar 

  191. Bosch FX, Castellsagué X, De Sanjosé. HPV and cervical cancer: screening or vaccination? Br J Cancer 2008;98:15–21

    PubMed  CAS  Google Scholar 

  192. Joura EA, Leodolter S, Hernandez-Avila M et al. Efficacy of a quadrivalent prohylactic human papillomavirus (types 6,11,16 and 18) L1virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials. Lancet 2007;369:2161–70

    Google Scholar 

  193. Long HC. Management of metastatic cervical cancer. J Clin Oncol 2007;25:2966–74

    PubMed  CAS  Google Scholar 

  194. Mayrand MH, Duarte-Franco E, Rodrigues I et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med 2007;1579–88

    Google Scholar 

  195. Monk BJ, Tewari KS, Koh WJ. Multimodality therapy for locally advanced cervical carcinoma. J Clin Oncol 2007;25:2952–65

    PubMed  CAS  Google Scholar 

  196. Saslow D, Castle PE, Cox JT et al. ASCO Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin 2007;57:7–28

    PubMed  Google Scholar 

  197. Schiffman M, Castle PE, Jeronimo J et al. Human papillomavirus and cervical cancer. Lancet 2007;370:890–907

    PubMed  CAS  Google Scholar 

  198. Stanley M. Prophylactic HPV vaccines: prospects for eliminating ano-genital cancer. Br J Cancer 2007;96:1320–3

    PubMed  CAS  Google Scholar 

  199. Woodman CBJ, Collins SI, Young LS. The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer 2007;7:11–22

    PubMed  CAS  Google Scholar 

  200. http://www.nlm.nih.gov/medlineplus/cervicalcancer.html MedlinePlus

    Google Scholar 

  201. http://www.cancer.gov/cancerinfo/types/cervical NCI Cancer Topics

    Google Scholar 

  202. http://www.emedicine.com/med/topic324.htm E-medicine

    Google Scholar 

  203. Amant F, Moermann P, Timmermann D et al. Endometrial cancer. Lancet 2005;366:491–505

    PubMed  Google Scholar 

  204. Carey MS, Gawlik C, Fung-Kee-Fung M et al. Systematic review of systemic therapy for advanced or recurrent endometrial cancer. Gynecol Oncol 2006;101:158–67

    PubMed  CAS  Google Scholar 

  205. Fleming GF. Systemic chemotherapy for uterine carcinoma: metastatic and adjuvant. J Clin Oncol 2007;25:2983–90

    PubMed  CAS  Google Scholar 

  206. Hecht JL, Mutter Gl. Molecular and pathologic aspects of endometrial carcinogenesis. J Clin Oncol 2006;24:4783–91

    PubMed  CAS  Google Scholar 

  207. Humber CE, Tierney JF, Symonds RP et al. Chemotherapy for advanced, recurrent or metastatic endometrial cancer: a systematic review of Cochrane collaboration. Ann Oncol 2007;18:409–20

    PubMed  CAS  Google Scholar 

  208. Markman M. Hormonal therapy of endometrial cancer. Eur J Cancer 2005;41:673–5

    PubMed  CAS  Google Scholar 

  209. Million Women Study Collaborators. Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet 2005;365:1543–51

    Google Scholar 

  210. Polyzos NP, Pavlidis N, Paraskevaidis E et al. Randomized evidence on chemotherapy and hormonal therapy regimens for advanced endometrial cancer. Eur J Cancer 2006;42:319–26

    PubMed  CAS  Google Scholar 

  211. http://www.nlm.nih.gov/medlineplus/uterinecancer.html MedlinePlus

    Google Scholar 

  212. http://www.cancer.gov/cancertopics/types/endometrial NCI Cancer Topics

    Google Scholar 

  213. http://www.mayoclinic.com/health/endometrial-cancer/DS00306 Mayo Clinic

    Google Scholar 

  214. http://www.emedicine.com/MED/topic2832.htm E-medicine

    Google Scholar 

  215. Curtin JP, Blessing JA, Soper JT et al. Paclitaxel in the treatment of carcinosarcoma of the uterus: a gynecologic oncology group study. Gynecol Oncol 2001;83:268–70

    PubMed  CAS  Google Scholar 

  216. Kempson RL, Hendrickson MR. Smooth muscle, endometrial stromal, and mixed Mullerian tumors of the uterus. Mod Pathol 2000;13:328–42

    PubMed  CAS  Google Scholar 

  217. Nordal RN, Kjorstad KE, Stenwig AE et al. Leiomyosarcoma (LMS) and endometrial stromal sarcoma (ESS) of the uterus. Int J Gynecol Cancer 1993;3:110–15

    PubMed  Google Scholar 

  218. Sutton GP, Brunetto VL, Kilgore L et al. A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus. Gynecol Oncol 2000;79:147–53

    PubMed  CAS  Google Scholar 

  219. Toyoshima M, Akahira J, Matsunaga G et al. Clinical experience with combination paclitaxel and carboplatin therapy for advanced or recurrent carcinosarcoma of the uterus. Gynecol Oncol 2004;94:774–8

    PubMed  CAS  Google Scholar 

  220. Van Rijswijk REN, Vermorken JB, Reed N et al. Cisplatin, doxorubicin and ifosfamide in carcinosarcoma of the female genital tract. Eur J Cancer 2003;39:481–7

    PubMed  Google Scholar 

  221. Yamada SD, Burger RA, Brewster WR et al. Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus. Cancer 2000;88:2782–6

    PubMed  CAS  Google Scholar 

  222. http://www.cancer.org/docroot/cri/cri_2_3x.asp?dt=63 Am Cancer Soc

    Google Scholar 

  223. http://www.cancer.gov/cancertopics/types/uterinesarcoma NCI Cancer Topics

    Google Scholar 

  224. Creasman WT. Vaginal cancers. Curr Opin Obstet Gynecol. 2005:17:71–6

    PubMed  Google Scholar 

  225. Grigsby PW. Vaginal cancer. Curr Treat Options Oncol 2002;3:125–30

    PubMed  Google Scholar 

  226. http://www.nlm.nih.gov/medlineplus/vaginalcancer.html MedlinePlus

    Google Scholar 

  227. http://www.cancer.gov/cancertopics/types/vaginal NCI Cancer Topics

    Google Scholar 

  228. Coleman RL, Santoso JT. Vulvar carcinoma. Curr Treat Options Oncol 2000;1:177–90

    PubMed  CAS  Google Scholar 

  229. Fonseca-Moutinho JA. Recurrent vulvar cancer. Clin Obstet Gynecol 2005;48:879–83

    PubMed  Google Scholar 

  230. Geisler JP, Manahan KJ, Buller RE. Neoadjuvant chemotherapy in vulvar cancer: avoiding primary exenteration. Gynecol Oncol 2006;100:53–7

    PubMed  CAS  Google Scholar 

  231. Hakim AA, Terada KY. Sentinel node dissection in vulvar cancer. Curr Treat Options Oncol 2006;7:85–91

    PubMed  Google Scholar 

  232. Montana GS. Carcinoma of the vulva: combined modality treatment. Curr Treat Options Oncol 2004;5:85–95

    PubMed  Google Scholar 

  233. Rouzier R, Haddad B, Atallah D et al. Surgery for vulvar cancer. Clin Obstet Gynecol 2005;48:869–78

    PubMed  CAS  Google Scholar 

  234. Tyring SK. Vulvar squamous cell carcinoma: guidelines for early diagnosis and treatment. Am J Obstet Gynecol 2003;189(3 suppl):S17–23

    PubMed  Google Scholar 

  235. Van Seters M, Van Beurden M, Ten Kate FBW et al. Treatment of vulvar intraepithelial neoplasia with topical imiquimod. N Engl J Med 2008;358:1465–73

    PubMed  Google Scholar 

  236. http://www.nlm.nih.gov/medlineplus/vulvarcancer.html MedlinePlus

    Google Scholar 

  237. http://www.cancer.gov/cancertopics/types/vulvar NCI Cancer Topics

    Google Scholar 

  238. http://www.cancer.org/docroot/cri/cri_2_3x.asp?dt=45 Am Cancer Soc

    Google Scholar 

  239. http://www.emedicine.com/med/topic3296.htm E-medicine

    Google Scholar 

  240. Albers P, Albrecht W, Algaba F et al. Guidelines on testicular cancer. Eur Urol 2005;48:885–94

    PubMed  Google Scholar 

  241. Dearnaley D, Huddart R, Horwich A. Managing testicular cancer. BMJ 2001;322:1583–8

    PubMed  CAS  Google Scholar 

  242. De Wit R, Fizazi K. Controversies in the management of clinical stages I testis cancer. J Clin Oncol 2006;24:5482–92

    PubMed  Google Scholar 

  243. ESMO Guidelines Working Group. Testicular seminoma: ESMO Clinical Recommendation for diagnosis, treatment and follow-up. Ann Oncol 2007;18(suppl 2):ii40–1

    Google Scholar 

  244. ESMO Guidelines Working Group. Mixed or non-seminomatous germ-cell tumors: ESMO Clinical Recommendation for diagnosis, treatment and follow-up. Ann Oncol 2007;18(suppl 2):ii42–3

    Google Scholar 

  245. Horwich A, Shipley J, Huddart R. Testicular germ-cell cancer. Lancet 2006;367:754–65

    PubMed  CAS  Google Scholar 

  246. MacVicar GR, Pienta KJ. Testicular cancer. Curr Opin Oncol 2004;16:253–6

    PubMed  Google Scholar 

  247. Schmoll HJ, Souchon R, Krege S et al. European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 2004;15:1377–99

    PubMed  CAS  Google Scholar 

  248. Van Dijk MR, Steyerberg EW, Habbema JDF. Survival of non-seminomatous germ cell cancer patients according to the IGCC classification: An update based on meta-analysis. Eur J Cancer 2006;42:820–6

    PubMed  Google Scholar 

  249. http://tcrc.acor.org/ Testicular Cancer Resource Center

    Google Scholar 

  250. http://www.nlm.nih.gov/medlineplus/testicularcancer.html MedlinePlus

    Google Scholar 

  251. http://www.cancer.gov/cancertopics/types/testicular/ NCI Cancer Topics

    Google Scholar 

  252. http://www.nccn.org/professionals/physician_gls/PDF/
testicular.pdf NCCN Guideline

    Google Scholar 

  253. http://www.emedicine.com/med/topic3232.htm E-medicine

    Google Scholar 

  254. Bokemeyer C, Nichols CR, Droz JP et al. Extragonadal germ cell tumors of the mediastinum and retroperitoneum: results from an international analysis. J Clin Oncol 2002;20:1864–73

    PubMed  Google Scholar 

  255. De Giorgi U, Demirer T, Wandt H et al. Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors. Ann Oncol 2005;16:146–51

    PubMed  Google Scholar 

  256. Göbel U, Schneider DT, Calaminus G et al. Germ-cell tumors in childhood and adolescence. Ann Oncol 2000;11:263–71

    PubMed  Google Scholar 

  257. Hartmann JT, Nichols CR, Droz JP et al. Prognostic variables for response and outcome in patients with extragonadal germ-cell tumors. Ann Oncol 2002;13:1017–28

    PubMed  CAS  Google Scholar 

  258. Schmoll HJ, Souchon R, Krege S et al. European consensus on the diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 2004;15:1377–99

    PubMed  CAS  Google Scholar 

  259. http://tcrc.acor.org/egc.html Testicular Cancer Resource Center

    Google Scholar 

  260. http://www.cancer.gov/cancertopics/types/extragonadal-germ-cell/ NCI Cancer Topics

    Google Scholar 

  261. http://www.emedicine.com/MED/topic759.htm E-medicine

    Google Scholar 

  262. Antonarakis ES, Blackford AL, Garrett-MayerE et al. Survival in men with nonmetastatic prostate cancer treated with hormone therapy. J Clin Oncol 2007;25:4998–5008

    PubMed  CAS  Google Scholar 

  263. Basch EM, Somerfield MR, Beer TM et al. ASCO Endorsement of the Cancer Care Ontario Practice Guideline on nonhormonal therapy for men with metastatic hormone-refactory (castration-resistant) prostate cancer. J Clin Oncol 2007;25:5313–8

    PubMed  Google Scholar 

  264. ESMO Guidelines Working Group. Prostate cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol 2007;18(suppl 2):ii36–7

    Google Scholar 

  265. Lilja H, Ulmert D, Vickers AJ. Prostate-specific antigen and prostate cancer: prediction, detection and monitoring. Nat Rev Cancer 2008;8:268–78

    PubMed  CAS  Google Scholar 

  266. Loblaw DA, Virgo KS, Nam R et al. Initial hormonal management of androgen-sensitive metastatic, recurrent or progressive prostate cancer: 2006 Update of an ASCO Practice Guideline. J Clin Oncol 2007;25:1596–605

    PubMed  CAS  Google Scholar 

  267. Nelson WG, De Marzo AM, Isaacs WB. Prostate cancer. N Engl J Med 2003;349:366–81

    PubMed  CAS  Google Scholar 

  268. Speight JL, Roach M. Radiotherapy in the management of clinically localized prostate cancer: evolving standards, consensus, controversies and new directions. J Clin Oncol 2005;23:8176–85

    PubMed  Google Scholar 

  269. Taichman RS, Loberg RD, Mehra R et al. The evolving biology and treatment of prostate cancer. J Clin Invest 2007;117:2351–61

    PubMed  CAS  Google Scholar 

  270. Walsh PC, DeWeese Tl, Eisenberger MA. Localized Prostate Cancer. N Engl J Med 2007;357:2696–705

    PubMed  CAS  Google Scholar 

  271. http://www.nlm.nih.gov/medlineplus/prostatecancer.html MedlinePlus

    Google Scholar 

  272. http://www.cancer.gov/cancertopics/types/prostate NCI Cancer Topics

    Google Scholar 

  273. http://www.cdc.gov/CANCER/prostate/prostate.htm Ctr Disease Control

    Google Scholar 

  274. http://www.nccn.org/professionals/physician_gls/PDF/prostate.pdf NCCN Guideline

    Google Scholar 

  275. http://www.emedicine.com/med/UROLOGY.htm E-medicine

    Google Scholar 

  276. Castellsague X, Bosch FX, Munoz N et al. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med 2002;346:1105–12

    PubMed  Google Scholar 

  277. Culkin DJ, Beer TM. Advanced penile carcinoma. J Urol 2003;170(2 Pt 1):359–65

    PubMed  Google Scholar 

  278. McDougal WS. Advances in the treatment of carcinoma of the penis. Urology 2005;66(suppl 5):114–17

    PubMed  Google Scholar 

  279. Misra S, Chaturvedi A, Misra NC. Penile carcinoma: a challenge for the developing world. Lancet Oncol 2004;5:240–7

    PubMed  Google Scholar 

  280. Mosconi AM, Roila F, Gatta G et al. Cancer of the penis. Crit Rev Oncol Hematol 2005;53:165–77

    PubMed  Google Scholar 

  281. Rippentrop JM, Joslyn SA, Konety BR. Squamous cell carcinoma of the penis: evaluation of data from the surveillance, epidemiology, and end results program. Cancer 2004;101:1357–63

    PubMed  Google Scholar 

  282. Sanchez-Ortiz RF, Pettaway CA. The role of lymphadenectomy in penile cancer. Urol Oncol 2004;22:236–44

    PubMed  Google Scholar 

  283. Solsona E, Algaba F, Horenblas S et al. European Association of Urology Guidelines on Penile Cancer. Eur Urol 2004;46:1–8

    PubMed  CAS  Google Scholar 

  284. http://www.nlm.nih.gov/medlineplus/ency/article/001276.htm MedlinePlus

    Google Scholar 

  285. http://www.nci.nih.gov/cancertopics/pdq/treatment/penile/
HealthProfessional NCI Cancer Topics

    Google Scholar 

  286. http://www.emedicine.com/MED/topic3046.htm E-medicine

    Google Scholar 

  287. Costa LJ, Drabkin HA, Renal cell carcinoma: new developments in molecular biology and potential for targeted therapies. Oncologist 2007;12:1404–15

    PubMed  CAS  Google Scholar 

  288. Cohen HT, McGovern FJ. Renal-cell carcinoma. N Engl J Med 2005;353:2477–90

    PubMed  CAS  Google Scholar 

  289. Escudier B, Eisen T, Stadler WM et al. Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 2007;356:125–34

    PubMed  CAS  Google Scholar 

  290. Garcia JA, Rini Bl. Recent progress in the management of advanced renal cell carcinoma. CA Cancer J Clin 2007;57:112–25

    PubMed  Google Scholar 

  291. Hudes G, Carducci M, Tomczak P et al. Temsirolismus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med 2007;356:2271–81

    PubMed  CAS  Google Scholar 

  292. Lam JS, Breda A, Belldegrun AS et al. Evolving principles of surgical management and prognostic factors for outcome in renal cell carcinoma. J Clin Oncol 2006;24:5565–75

    PubMed  Google Scholar 

  293. Motzer RJ, Hutson TE, Tomczak P et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 2007;356:115–24

    PubMed  CAS  Google Scholar 

  294. Pavlovich CP, Schmidt LS. Searching for the hereditary causes of renal cell carcinoma. Nat Rev Cancer 2004;4:381–93

    PubMed  CAS  Google Scholar 

  295. Yang JC, Childs R. Immunotherapy for renal cell cancer. J Clin Oncol 2006;24:5576–83

    PubMed  CAS  Google Scholar 

  296. http://www.cancer.gov/cancertopics/types/kidney NCI Cancer Topics

    Google Scholar 

  297. http://www.nlm.nih.gov/medlineplus/kidneycancer.html Medline Plus

    Google Scholar 

  298. http://www.emedicine.com/MED/topic2002.htm E-medicine

    Google Scholar 

  299. http://www.nccn.org/professionals/physician_gls/PDF/kidney.pdf NCCN Guideline

    Google Scholar 

  300. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Adjuvant chemotherapy for invasive bladder cancer. Cochrane Database Syst Rev. 2006;(2):CD006018

    Google Scholar 

  301. Amiel GE, Lerner SP. Combining surgery and chemotherapy for invasive bladder cancer. Expert Rev Anticancer Ther 2006;6:281–91

    PubMed  CAS  Google Scholar 

  302. Bamias A, Tiliakos I, Karali MD et al. Systemic chemotherapy in inoperable or metastatic bladder cancer. Ann Oncol 2006;17:553–61

    PubMed  CAS  Google Scholar 

  303. Borden LS Jr, Clark PE, Hall MC. Bladder cancer. Curr Opin Oncol 2005;17:275–80

    PubMed  Google Scholar 

  304. ESMO Guidelines Working Group. Invasive bladder cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol 2007;18(suppl 2):ii38–9

    Google Scholar 

  305. Garcia JA, Dreicer R. Systemic chemotherapy for advanced bladder cancer: update and controversies. J Clin Oncol 2006;24:5545–51

    PubMed  CAS  Google Scholar 

  306. Habuchi T, Marberger M, Droller MJ et al. Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers. Urology 2005;66(6 suppl 1):64–74

    PubMed  Google Scholar 

  307. Rödel C, Weiss C, Sauer R. Trimodality treatment and selective organ preservation for bladder cancer. J Clin Oncol 2006;24:5536–44

    PubMed  Google Scholar 

  308. Wolff EM, Liang G, Jones PA. Mechanisms of disease: genetic and epigenetic alterations that drive bladder cancer. Nat Clin Pract Urol 2005;2:502–10

    PubMed  CAS  Google Scholar 

  309. http://www.cancer.gov/cancertopics/types/bladder NCI Cancer Topics

    Google Scholar 

  310. http://www.nlm.nih.gov/medlineplus/bladdercancer.html MedlinePlus

    Google Scholar 

  311. http://www.emedicine.com/MED/topic2344.htm E-medicine

    Google Scholar 

  312. http://www.nccn.org/professionals/physician_gls/PDF/bladder.pdf NCCN Guideline

    Google Scholar 

  313. Baudin E, Schlumberger M. New therapeutic approaches for metastatic thyroid carcinoma. Lancet Oncol 2007;8:148–56

    PubMed  CAS  Google Scholar 

  314. Fernandes JK, Day TA, Richardson MS et al. Overview of the management of differentiated thyroid cancer. Curr Treat Options Oncol 2005;6:47–57

    PubMed  Google Scholar 

  315. Kebebew E, Greenspan FS, Clark OH et al. Anaplastic thyroid carcinoma. Cancer 2005;103:1330–5

    PubMed  Google Scholar 

  316. Kondo T, Ezzat S, Asa SL. Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer 2006;6:292–306

    PubMed  CAS  Google Scholar 

  317. Patel KN, Shaha AR. Poorly differentiated and anaplastic thyroid cancer. Cancer Control. 2006; 13:119–28

    PubMed  Google Scholar 

  318. Sherman SI. Thyroid carcinoma. Lancet 2003;361:501–11

    PubMed  Google Scholar 

  319. Traugott A, Moley JF. Medullary thyroid cancer: medical management and follow-up. Curr Treat Options Oncol 2005;6:339–46

    PubMed  Google Scholar 

  320. http://www.endocrineweb.com/thyroidca.html Endocrine Web

    Google Scholar 

  321. http://www.cancer.gov/cancertopics/types/thyroid NCI Cancer Topics

    Google Scholar 

  322. http://www.nlm.nih.gov/medlineplus/thyroidcancer.html MedlinePlus

    Google Scholar 

  323. http://www.emedicine.com/med/ONCOLOGY.htm E-medicine

    Google Scholar 

  324. http://www.nccn.org/professionals/physician_gls/PDF/thyroid.pdf NCCN Guideline

    Google Scholar 

  325. Durá I, Salazar R, Casanovas O et al. New drug development in digestive neuroendocrine tumors. Ann Oncol 2007;18:1307–13

    Google Scholar 

  326. Kulke M. Advances in the treatment of neuroendocrine tumors. Curr Treat Options Oncol 2005;6:397–409

    PubMed  Google Scholar 

  327. Lal A, Chen H. Treatment of advanced carcinoid tumors. Curr Opin Oncol 2006;18:9–15

    PubMed  Google Scholar 

  328. Oberg K, Kvols L, Caplin M et al. Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system. Ann Oncol 2004;15:966–73

    PubMed  CAS  Google Scholar 

  329. Ramage JK, Davies AH, Ardill J et al. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut 2005;54(suppl 4):iv1–16

    PubMed  Google Scholar 

  330. Soga J. Early-stage carcinoids of the gastrointestinal tract. Cancer 2005;103:1587–95

    PubMed  Google Scholar 

  331. Zuetenhorst JM, Taal BG. Metastatic carcinoid tumors. Oncologist 2005;10:123–31

    PubMed  Google Scholar 

  332. http://www.carcinoid.org/ Carcinoid Foundation

    Google Scholar 

  333. http://www.nlm.nih.gov/medlineplus/carcinoidtumors.html Medline Plus

    Google Scholar 

  334. http://www.cancer.gov/cancertopics/types/NCI
gastrointestinalcarcinoid/ Cancer Topics

    Google Scholar 

  335. http://www.nccn.org/professionals/physician_gls/PDF/
neuroendocrine.pdf NCCN Guideline

    Google Scholar 

  336. http://www.emedicine.com/med/topic271.htm E-medicine

    Google Scholar 

  337. Kim WY, Kaelin WG. Role of VHL mutation in human cancer. J Clin Oncol 2004;24:4991–5004

    Google Scholar 

  338. Lenders JWM, Eisenhofer G, Mannelli M et al. Phaeochromocytoma. Lancet 2005;366:665–75

    PubMed  Google Scholar 

  339. Lonser RR, Glenn GM, Walther M et al. Von Hippel-Lindau disease. Lancet 2003;361:2059–67

    PubMed  CAS  Google Scholar 

  340. Marx SJ. Molecular genetics of multiple endocrine neoplasia types 1 and 2. Nat Rev Cancer 2005;5:367–75

    PubMed  CAS  Google Scholar 

  341. Neumann HPH, Bausch B, McWhinney SR et al. Germline mutations in nonsyndromic pheochromocytoma. N Engl J Med 2002;346:1459–66

    PubMed  CAS  Google Scholar 

  342. Schiavi F, Boedecker cc, Bausch B et al. Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene. JAMA 5005;294:2057–63

    PubMed  CAS  Google Scholar 

  343. Scholz T, Eisenhofer G, Pacak K et al. Current treatment of malignant pheochromocytoma. J Clin Endocrinol Metab 2007;92:121–25

    Google Scholar 

  344. http://www.cancer.gov/cancertopics/types/pheochromocytoma/ NCI Cancer Topics

    Google Scholar 

  345. http://www.nlm.nih.gov/medlineplus/pheochromocytoma.html MedlinePlus

    Google Scholar 

  346. http://www.emedicine.com/med/topic1816.htm E-medicine

    Google Scholar 

  347. Cobb WS, Kercher KW, Sing RF et al. Laparoscopic adrenalectomy for malignancy. Am J Surg 2005;189:405–11

    PubMed  Google Scholar 

  348. Kirschner LS. Emerging treatment strategies for adrenocortical carcinoma. J Clin Endocrinol Metab 2006;91:14–21

    PubMed  CAS  Google Scholar 

  349. Libe R, Bertherat J. Molecular genetics of adrenocortical tumours, from familial to sporadic diseases. Eur J Endocrinol 2005;153:477–87

    PubMed  CAS  Google Scholar 

  350. Shen WT, Sturgeon C, Duh OY. From incidentaloma to adrenocortical carcinoma: the surgical management of adrenal tumors. J Surg Oncol 2005;89:186–92

    PubMed  Google Scholar 

  351. Sidhu S, Sywak M, Robinson B et al. Adrenocortical cancer. Curr Opin Oncol 2004;16:13–18

    PubMed  Google Scholar 

  352. Young WF. The incidentally discovered adrenal mass. N Engl J Med 2007;356:601–10

    PubMed  CAS  Google Scholar 

  353. http://www.endotext.org/adrenal Endotext

    Google Scholar 

  354. http://www.ensat.org/ EU Network Adrenal Tumors

    Google Scholar 

  355. http://www.ganimed-net.de GANIMED

    Google Scholar 

  356. http://www.firm-act.org ACC Study

    Google Scholar 

  357. www.conn-register.de Conn Register

    Google Scholar 

  358. http://www.cancer.gov/cancertopics/pdq/treatment/adrenocortical Nci Cancer Topics

    Google Scholar 

  359. Bradshaw C, Kakar SS: Pituitary tumor transforming gene: an important gene in normal cellular functions and tumorigenesis. Histol Histopathol. 2007; 22:219–226.

    PubMed  CAS  Google Scholar 

  360. Melmed S, Acromegaly. N Engl J Med 2006; 355:2558–73.

    PubMed  CAS  Google Scholar 

  361. Minematsu T, Miyai S, Kajiya H, et al. Recent progress in studies of pituitary tumor pathogenesis. Endocrine 2005;28:37–41.

    PubMed  CAS  Google Scholar 

  362. Kaltsas GA, Grossmann AB: Malignant pituitary tumors. Pituitary 1998(1): 69–81.

    PubMed  CAS  Google Scholar 

  363. Simard MF: Pituitary tumor endocrinopathies and their endocrine evaluation. Neurosurg Clin N Am. 2003; 14:41–54.

    PubMed  Google Scholar 

  364. http://www.endotext.com/neuroendo

    Google Scholar 

  365. http://www.ninds.nih.gov/disorders/pituitary_tumors/pituitary_tumors.htm

    Google Scholar 

  366. http://www.cancer.gov/cancertopics/pdq/treatment/pituitary/healthprofessional

    Google Scholar 

  367. Curtin JA, Fridlyand J, Kageshita T et al. Distinct sets of genetic alterations in melanoma. N Engl J Med 2005;353:2135–47

    PubMed  CAS  Google Scholar 

  368. ESMO Guidelines Working Group. Cutaneous malignant melanoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol 2007;18(suppl 2):ii71–3

    Google Scholar 

  369. Fears TR, Guerry DP, Pfeiffer RM et al. Identifying individuals at high risk of melanoma: a practical predictor of absolute risk. J Clin Oncol 2006;24:3590–6

    PubMed  Google Scholar 

  370. Ives NJ, Stowe RL, Lorigan P et al. Chemotherapy compared with biochemotherapy for treatment of metastatic melanoma. J Clin Oncol 2007;25:5426–34

    PubMed  CAS  Google Scholar 

  371. Miller AJ, Mihm MC. Melanoma. N Engl J Med 2006;355:51–65

    PubMed  CAS  Google Scholar 

  372. Morton DL, Thompson JF, Chochran AJ et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl j Med 2006;355:1307–17

    PubMed  CAS  Google Scholar 

  373. Scoggins CR, Chagpar AB, Martin RC et al. Should sentinel lymph-node biopsy be used routinely for staging melanoma and breast cancers? Nat Clin Pract Oncol 2005;2:448–55

    PubMed  Google Scholar 

  374. Thompson JF, Scolyer RA, Kefford RF. Cutaneous melanoma. Lancet 2005;365:687–701

    PubMed  CAS  Google Scholar 

  375. Verma S, Quirt I, McCready D et al. Systematic review of systemic adjuvant therapy for patients at high risk for recurrent melanoma. Cancer 2006;106:1431–42

    PubMed  CAS  Google Scholar 

  376. http://www.cancer.gov/cancertopics/types/melanoma NCI Cancer Topics

    Google Scholar 

  377. http://www.nlm.nih.gov/medlineplus/melanoma.html MedlinePlus

    Google Scholar 

  378. http://www.emedicine.com/DERM/topic257.html E-medicine

    Google Scholar 

  379. http://www.nccn.org/professionals/physician_gls/PDF/melanoma.pdf NCCN Guideline

    Google Scholar 

  380. http://www.sign.ac.uk/pdf/sign72.pdf SIGN Guideline

    Google Scholar 

  381. Bath FJ, Bong J, Perkins W et al. Interventions for basal cell carcinoma of the skin. Cochrane Database Syst Rev 2003;2:CD003412

    PubMed  Google Scholar 

  382. Brooke RC. Basal cell carcinoma. Clin Med 2005;5:551–4

    PubMed  Google Scholar 

  383. Rubin AI. Basal cell carcinoma. N Engl J Med 2005;353:2262–9

    PubMed  CAS  Google Scholar 

  384. http://www.nlm.nih.gov/medlineplus/ency/article/000824.htm MedlinePlus

    Google Scholar 

  385. http://www.emedicine.com/med/topic214.htm E-medicine

    Google Scholar 

  386. http://www.skincancer.org/basal/index.php Skin Cancer Foundation

    Google Scholar 

  387. Albert MR, Weinstock MA. Keratinocyte carcinoma. CA Cancer J Clin 2003;53:292–302

    PubMed  Google Scholar 

  388. Boukamp P. Non-melanoma skin cancer: what drives tumor development and progression? Carcinogenesis 2005;26:1657–67

    PubMed  CAS  Google Scholar 

  389. Lane JE, Kent DE. Surgical margins in the treatment of nonmelanoma skin cancer and Mohs micrographic surgery. Curr Surg 2005;62:518–26

    PubMed  Google Scholar 

  390. Rinker MH, Fenske NA, Scalf LA et al. Histologic variants of squamous cell carcinoma of the skin. Cancer Control 2001;8:354–63

    PubMed  CAS  Google Scholar 

  391. http://www.cancer.gov/cancertopics/types/skin NCI Cancer Topics

    Google Scholar 

  392. http://www.nlm.nih.gov/medlineplus/ency/article/000829.htm MedlinePlus

    Google Scholar 

  393. http://www.emedicine.com/DERM/topic401.htm E-medicine

    Google Scholar 

  394. http://www.skincancer.org/squamous/index.php Skin Cancer Foundation

    Google Scholar 

  395. Goessling W, McKee PH, Mayer RJ. Merkel cell carcinoma. J Clin Oncol 2002;20:588–598

    PubMed  Google Scholar 

  396. McAfee WJ, Morris GG, Mendenhall CM et al. Merkel cell carcinoma: treatment and outcomes. Cancer 2005;104:1761–4

    PubMed  Google Scholar 

  397. Pectasides D, Pectasides M, Economopoulos T. Merkel cell cancer of the skin. Ann Oncol 2006;17:1489–95

    PubMed  CAS  Google Scholar 

  398. Poulsen M. Merkel-cell carcinoma of the skin. Lancet Oncol 2004;5:593–9

    PubMed  Google Scholar 

  399. http://www.cancer.gov/cancertopics/pdq/treatment/NCImerkelcell/HealthProfessional Cancer Topics

    Google Scholar 

  400. http://www.emedicine.com/DERM/topic262.htm E-medicine

    Google Scholar 

  401. Clark MA, Fisher C, Judson I et al. Soft-tissue sarcomas in adults. N Engl J Med 2005;353:701–11

    PubMed  CAS  Google Scholar 

  402. Cormier JN, Pollock RE. Soft tissue sarcomas. CA Cancer J Clin 2004;54:94–109

    PubMed  Google Scholar 

  403. ESMO Guidelines Working Group. Soft tissue sarcomas: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol 2007;18(Suppl.2):ii74–6

    Google Scholar 

  404. Kotilingam D, Lev DC, Lazar AJF et al. Staging soft tissue sarcoma: evolution and change. CA Cancer J Clin 2006;56:282–91

    PubMed  Google Scholar 

  405. Mocellin S, Rossi CR, Brandes A et al. Adult soft tissue sarcomas: conventional therapies and molecularly targeted approaches. Cancer Treat Rev 2006;32:9–27

    PubMed  CAS  Google Scholar 

  406. http://www.cancer.gov/cancertopics/types/soft-tissue-sarcoma/ NCI Cancer Topics

    Google Scholar 

  407. http://www.nlm.nih.gov/medlineplus/softtissuesarcoma.html MedlinePlus

    Google Scholar 

  408. http://www.nccn.org/professionals/physician_gls/PDF/sarcoma.pdf NCCN Guideline

    Google Scholar 

  409. Blay JY, Bonvalot S, Casali P et al. Consensus meeting for the management of gastrointestinal stromal tumors (GISTs). Ann Oncol 2005;16:566–78

    PubMed  Google Scholar 

  410. Chen LL, Sabripour M, Andtbacka RH et al. Imatinib resistance in gastrointestinal stromal tumors. Curr Oncol Rep 2005;7:293–9

    PubMed  CAS  Google Scholar 

  411. Demetri G, Von Mehren M, Blanke CD et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002;347:472–80

    PubMed  CAS  Google Scholar 

  412. ESMO Guidelines Working Group. Gastrointestinal stromal tumors: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol 2007;18(Suppl.2):ii27–9

    Google Scholar 

  413. Kosmadakis N, Visvardis EE, Kartsaklis P et al. The role of surgery in the management of GISTs in the era of imatinib mesylate effectiveness. Surg Oncol 2005;14:75–84

    PubMed  Google Scholar 

  414. Rubin BP, Heinrich MC, Corless CL. Gastrointestinal stromal tumor. Lancet 2007;369:1731–41

    PubMed  CAS  Google Scholar 

  415. Van der Zwan SM, De Matteo RP. Gastrointestinal stromal tumor. Cancer 2005;104:1781–8

    PubMed  Google Scholar 

  416. http://www.emedicine.com/radio/topic388.htm E-medicine

    Google Scholar 

  417. http://www.cancer.org/docroot/CRI/CRI_2_3x.asp?dt=81 Am Cancer Soc

    Google Scholar 

  418. http://www.nccn.org/professionals/physician_gls/PDF/sarcoma.pdf NCCN Guideline

    Google Scholar 

  419. Bernstein M, Kovar H, Paulussen M et al. Ewing’s sarcoma family of tumors: current management. Oncologist 2006;11:503–19

    PubMed  CAS  Google Scholar 

  420. Ek ET, Choong PF. The role of high-dose therapy and autologous stem cell transplantation for pediatric bone and soft tissue sarcomas. Expert Rev Anticancer Ther 2006;6:225–37

    PubMed  CAS  Google Scholar 

  421. ESMO Guidelines Working Group. Ewing’s sarcoma of bone: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol 2007;18(Suppl.2):ii79–80

    Google Scholar 

  422. Janknecht R. EWS-ETS oncoproteins: the linchpins of Ewing tumors. Gene 2005;363:1–14

    PubMed  CAS  Google Scholar 

  423. Kennedy JG, Frelinghuysen P, Hoang BH. Ewing sarcoma: current concepts in diagnosis and treatment. Curr Opin Pediatr 2003;15:53–7

    PubMed  Google Scholar 

  424. Thacker MM, Temple HT, Scully SP. Current treatment for Ewing’s sarcoma. Expert Rev Anticancer Ther 2005;5:319–31

    PubMed  CAS  Google Scholar 

  425. http://euro-ewing.uni-muenster.de/ EURO-E.W.I.N.G. 99

    Google Scholar 

  426. http://www.cancer.gov/cancertopics/types/ewings NCI Cancer Topics

    Google Scholar 

  427. http://www.nlm.nih.gov/medlineplus/ency/article/001302.htm MedlinePlus

    Google Scholar 

  428. http://www.emedicine.com/RADIO/topic275.htm E-medicine

    Google Scholar 

  429. ESMO Guidelines Working Group. Osteosarcoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol 2007;18(Suppl.2):ii77–8

    Google Scholar 

  430. Ferguson WS, Goorin AM. Current treatment of osteosarcoma. Cancer Invest 2001;19:292–315

    PubMed  CAS  Google Scholar 

  431. Grimer RJ. Surgical options for children with osteosarcoma. Lancet Oncol 2005;6:85–92

    PubMed  Google Scholar 

  432. Heck RK, Peabody TD, Simon MA. Staging of primary malignancies of bone. CA Cancer J Clin 2006;56:366–75

    PubMed  Google Scholar 

  433. Marina N, Gebhardt M, Teot L et al. Biology and therapeutic advances for pediatric osteosarcoma. Oncologist 2004;9:422–41

    PubMed  Google Scholar 

  434. Miller SL, Hoffer FA. Malignant and benign bone tumors. Radiol Clin North Am 2001;39:673–99

    PubMed  CAS  Google Scholar 

  435. Ngarajan R, Clohisy D, Weigel B. New paradigms for therapy of osteosarcoma. Curr Oncol Rep 2005;7:410–4

    Google Scholar 

  436. Wang LL. Biology of osteogenic sarcoma. Cancer J 2005;11:294–305

    PubMed  CAS  Google Scholar 

  437. Wittig JC, Bickels J, Priebat D et al. Osteosarcoma: a multidisciplinary approach to diagnosis and treatment. Am Fam Physician 2002;65:1123–32

    PubMed  Google Scholar 

  438. http://www.euramos.org/ Eur Am Osteosarc Grp

    Google Scholar 

  439. http://www.emedicine.com/orthoped/topic531.htm E-medicine

    Google Scholar 

  440. http://www.cancer.gov/cancertopics/pdq/treatment/
osteosarcoma/HealthProfessional NCI Cancer Topics

    Google Scholar 

  441. http://www.nlm.nih.gov/medlineplus/ency/article/001650.htm MedlinePlus

    Google Scholar 

  442. Behin A, Hoang-Xuan K, Carpentier AF et al. Primary brain tumors in adults. Lancet 2003;361:323–31

    PubMed  Google Scholar 

  443. ESMO Guidelines Working Group. Malignant glioma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol 2007;18(Suppl.2):ii69–70

    Google Scholar 

  444. Grier JT, Batchelor T. Low-grade gliomas in adults. Oncologist 2006;11:681–93

    PubMed  Google Scholar 

  445. Jaeckle KA, Ballmann KV, Rao RD et al. Current strategies in treatment of oligodendroglioma: evolution of molecular signatures of response. J Clin Oncol 2006;24:1246–52

    PubMed  CAS  Google Scholar 

  446. Lang FF, Gilbert MR. Diffusely infiltrative low-grade gliomas in adults. J Clin Oncol 2006;24:1236–45

    PubMed  CAS  Google Scholar 

  447. Maris JM, Hogarty MD, Bagatell R et al. Neuroblastoma. Lancet 2007;369:2106–20

    PubMed  CAS  Google Scholar 

  448. Reardon DA, Rich JN, Friedman HS et al. Recent advances in the treatment of malignant astrocytoma. J Clin Oncol 2006;24:1253–65

    PubMed  CAS  Google Scholar 

  449. Stupp R, Hegi ME, Gilbert MR et al. Chemoradiotherapy in malignant glioma: standard of care and future directions. J Clin Oncol 2007;25:4127–36

    PubMed  CAS  Google Scholar 

  450. Van den Bent MJ, Hegi ME, Stupp R. Recent developments in the use of chemotherapy in brain tumors. Eur J Cancer 2006;42:582–8

    PubMed  Google Scholar 

  451. http://www.nlm.nih.gov/medlineplus/braincancer.html MedlinePlus

    Google Scholar 

  452. http://www.cancer.gov/cancertopics/types/brain/ NCI Cancer Topics

    Google Scholar 

  453. http://brain.mgh.harvard.edu Harvard Univ

    Google Scholar 

  454. http://cbtrus.org Brain Tumor Registry

    Google Scholar 

  455. http://www.tbts.org/ Brain Tumor Society

    Google Scholar 

  456. http://www.abta.org/ Brain Tumor Assoc

    Google Scholar 

  457. Chorost MI, Lee MC, Yeoh CB et al. Unknown primary. J Surg Oncol 2004;87:191–203

    PubMed  Google Scholar 

  458. ESMO Guidelines Working Group. Cancer of unknown primary site: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol 2007;18(Suppl.2):ii81–2

    Google Scholar 

  459. Hillen HF. Unknown primary tumours. Postgrad Med J 2000;76:690–3

    PubMed  CAS  Google Scholar 

  460. Pavlidis N, Fizazi K. Cancer of unknown primary (CUP). Crit Rev Oncol Hematol 2005;54:243–50

    PubMed  Google Scholar 

  461. Van de Wouw AJ, Jansen RLH, Speel EJM et al. The unknown biology of the unknown primary tumour. Ann Oncol 2003;14:191–6

    PubMed  Google Scholar 

  462. Varadhachary GR, Abbruzzese JL, Lenzi R. Diagnostic strategies for unknown primary cancer. Cancer 2004;100:1776–85

    PubMed  CAS  Google Scholar 

  463. http://www.cancer.gov/cancertopics/types/unknownprimary NCI Cancer Topics

    Google Scholar 

  464. http://www.emedicine.com/MED/topic1463.htm E-medicine

    Google Scholar 

  465. http://www.unknownprimarycancer.com/ Sarah Cannon Ctr

    Google Scholar 

  466. Bogenrieder T, Herlyn M. Axis of evil. Molecular mechanisms of cancer metastasis. Oncogene 2003;22:6524–36

    PubMed  CAS  Google Scholar 

  467. Cao Y. Emerging mechanisms of tumor lymphangiogenesis and lymphatic metastasis. Nat Rev Cancer 2005;5:735–42

    PubMed  CAS  Google Scholar 

  468. Eccles SA, Welch DR. Metastasis: recent discoveries and novel treatment strategies. Lancet 2007;369:1742–57

    PubMed  CAS  Google Scholar 

  469. Entschladen F, Drell TL, Lang K et al. Tumor-cell migration, invasion and metastasis: navigation by neurotransmitters. Lancet Oncol 2004;5:254–8

    PubMed  CAS  Google Scholar 

  470. Hunter K. Host genetics influence tumour metastasis. Nat Rev Cancer 2006;6:141–6

    PubMed  CAS  Google Scholar 

  471. Liotta LA, Kohn EC. The microenvironment of the tumour-host interface. Nature 2001;411:375–9

    PubMed  CAS  Google Scholar 

  472. Pantel K, Brakenhoff RH. Dissecting the metastatic cascade. Nat Rev Cancer 2004;4:448–56

    PubMed  CAS  Google Scholar 

  473. Steeg PS. Tumor metastasis: mechanistics insights and clinical challanges. Nature Med 2006;12:895–904

    PubMed  CAS  Google Scholar 

  474. Weigelt B, Peterse JL, Van’t Veer LJ. Breast cancer metastasis: markers and models. Nat Rev Cancer 2005;5:591–602

    PubMed  CAS  Google Scholar 

  475. http://www.nlm.nih.gov/medlineplus/ency/article/002260.htm Metastasis, Medline Plus

    Google Scholar 

  476. http://www.path.sunysb.edu/courses/im/ Metastasis, New York University

    Google Scholar 

  477. http://www.cancer.gov/cancertopics/understandingcancer/
angiogenesis NCI Cancer Topics

    Google Scholar 

  478. Eichler AF, Loeffler JS. Multidisciplinary management of brain metastases. Oncologist 2007;12:884–98

    PubMed  CAS  Google Scholar 

  479. Kaap EC, Niel CG, Vecht CJ. Therapeutic management of brain metastasis. Lancet Neurol 2005;4:289–98

    Google Scholar 

  480. Khuntia D, Brown P, Li J et al. Whole-brain radiotherapy in the management of brain mestastasis. J Clin Oncol 2006;24:1295–304

    PubMed  CAS  Google Scholar 

  481. Klimo P, Schmidt MH. Surgical management of spinal metastases. Oncologist 2004;9:188–96

    PubMed  Google Scholar 

  482. Langer CL, Mehta MP. Current management of brain metastases, with a focus on systemic options. J Clin Oncol 2005;23:6207–19

    PubMed  CAS  Google Scholar 

  483. Van den Bent MJ. The role of chemotherapy in brain metastases. Eur J Cancer 2003;39:2114–20

    PubMed  Google Scholar 

  484. Vogelbaum MA, Suh JH. Resectable brain metastases. J Clin Oncol 2006;24:1289–94

    PubMed  Google Scholar 

  485. http://neuroscript.com/neuroscript.com/index.htm Neuroscript

    Google Scholar 

  486. http://www.nlm.nih.gov/medlineplus/ency/
article/000769.htm Metastatic Brain Tumor, Medline Plus

    Google Scholar 

  487. http://www.emedicine.com/Radio/topic101.htm E-medicine

    Google Scholar 

  488. Balm M, Hammack J. Leptomeningeal carcinomatosis: presenting features and prognostic factors. Arch Neurol 1996;53:626–32

    PubMed  CAS  Google Scholar 

  489. Chamberlain MC. Combined-modality treatment of leptomeningeal gliomatosis. Neurosurgery 2003;52:324

    PubMed  Google Scholar 

  490. Kesari S, Batchelor TT. Leptomeningeal metastases. Neurol Clin 2003;21:25–66

    PubMed  Google Scholar 

  491. Omuro AM, Lallana EC, Bilsky MH, DeAngelis LM. Ventriculoperitoneal shunt in patients with leptomeningeal metastasis. Neurology 2005;64:1625–7

    PubMed  Google Scholar 

  492. http://www.emedicine.com/neuro/topic188.htm

    Google Scholar 

  493. http://cancerweb.ncl.ac.uk/cancernet/103859.html

    Google Scholar 

  494. Briccoli A, Rocca M, Salone M et al. Resection of recurrent pulmonary metastases in patients with osteosarcoma. Cancer 2005;104:1721–5

    PubMed  Google Scholar 

  495. Kondo H, Okumura T, Ohde Y et al. Surgical treatment for metastatic malignancies. Pulmonary metastasis: indications and outcome. Int J Clin Oncol 2005;10:81–5

    PubMed  Google Scholar 

  496. Schreiber G, Pitterle D, Kim YC et al. Molecular genetic analysis of primary lung cancer and cancer metastatic to the lung. Anticancer Res 1999;19:1109–15

    PubMed  CAS  Google Scholar 

  497. Thao B, Schwartz LH, Moskowitz CS et al. Pulmonary metastases: effect of CT section thickness on measurement: initial experience. Radiology 2005;234:934–9

    Google Scholar 

  498. Van Putte BP, Hendriks JM, Romijn S et al. Isolated lung perfusion for the treatment of pulmonary metastases. Surg Oncol 2003;12:187–93

    PubMed  Google Scholar 

  499. Yoneda KY, Louie S, Shelton DK. Approach to pulmonary metastases. Curr Opin Pulm Med 2000;6:356–63

    PubMed  CAS  Google Scholar 

  500. http://www.nml.nih.gov/medlineplus/ency/
article/000097.htm Pulmonary Metastases, Medline Plus

    Google Scholar 

  501. http://www.emedicine.com/med/topic2987.htm E-medicine

    Google Scholar 

  502. http://www.meddean.luc.edu/lumen/MedEd/medicine/
pulmonar/cxr/met.htm Loyola University

    Google Scholar 

  503. http://www.ctsnet.org/ Cardiothoracic Surgery Network

    Google Scholar 

  504. http://cancernet.nci.nih.gov CancerNet, National Cancer Institute

    Google Scholar 

  505. Khatri VP, Petrelli NJ, Belghiti J. Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit? J Clin Oncol 2005;23:8490–9

    PubMed  Google Scholar 

  506. Malafosse R, Penna C, Sa Cunha A et al. Surgical management of hepatic metastases from colorectal malignancies. Ann Oncol 2001;12:887–94

    PubMed  CAS  Google Scholar 

  507. Mocellin S, Pilati P, Lise M et al. Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era? J Clin Oncol 2007;25:5649–54

    PubMed  Google Scholar 

  508. Pawlik TM, Schulick RD, Choti MA. Expanding criteria for resectability of colorectal liver metastases. Oncologist 2008;13:51–64

    PubMed  Google Scholar 

  509. Venook AP, Warren RS. Therapeutic approaches to metastasis confined to the liver. Curr Oncol Rep 2001;3:109–15

    PubMed  CAS  Google Scholar 

  510. http://www.nlm.nih.gov/medlineplus/ency/article/000277.htm Liver Metastases, Medline Plus

    Google Scholar 

  511. http://www.emedicine.com/RADIO/topic 394.htm E-medicine

    Google Scholar 

  512. http://www.aasld.org/ Liver Diseases

    Google Scholar 

  513. http://www.liverfoundation.org/ American Liver Foundation

    Google Scholar 

  514. http://www.livercancer.com/ Liver Cancer Network

    Google Scholar 

  515. http://www3.mdanderson.org/departments/
liver/metastasis.htm Liver Metastases, MD Anderson

    Google Scholar 

  516. Coleman RE. Management of bone metastases. Oncologist 2000;5:463–70

    PubMed  CAS  Google Scholar 

  517. Mercadante S, Fulfaro F. Management of painful bone metastases. Curr Opin Oncol 2007;19:308–14

    PubMed  Google Scholar 

  518. Roodman GD. Mechanisms of bone metastasis. N Engl J Med 2004;350:1655–64

    PubMed  CAS  Google Scholar 

  519. Serafini AN. Therapy of metastatic bone pain. J Nucl Med 2001;42:895–906

    PubMed  CAS  Google Scholar 

  520. Van Poznack C, Nadal C. Bone integrity and bone metastases in breast cancer. Curr Oncol Rep 2006;8:22–8

    Google Scholar 

  521. http://www.cancer.med.umich.edu/learn/
bonemetsfacts.htm Bone Metastases, Michigan University

    Google Scholar 

  522. http://www.emedicine.com/radio/topic88.htm E-medicine

    Google Scholar 

  523. http://www.stat.washington.edu/TALARIA/LS2.3.1.html Bone Metastases, Washington University

    Google Scholar 

  524. http://www.bonetumor.com/page67.html Bone Metastases, Bonetumor.Org

    Google Scholar 

  525. Abu-Shakra M, Buskila D, Ehrenfeld M et al. Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies. Ann Rheum Dis 2001;60:433–41

    PubMed  CAS  Google Scholar 

  526. Bollanti L, Riondino G, Strollo F. Endocrine paraneoplastic syndromes with special reference to the elderly. Endocrine 2001;14:151–7

    PubMed  CAS  Google Scholar 

  527. Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med 2003;349:1543–54

    PubMed  CAS  Google Scholar 

  528. De Beukelaar JW, Smitt PAS. Managing paraneoplastic neurological disorders. Oncologist 2006;11:292–305

    PubMed  Google Scholar 

  529. Stone SP, Buescher LS. Life-threatening paraneoplastic neurological disorders. Oncologist 2006;23:301–6

    Google Scholar 

  530. http://www.emedicine.com/MED/topic1747 E-medicine

    Google Scholar 

  531. http://www.emedicine.com/derm/topic552 E-medicine

    Google Scholar 

  532. http://www.neuro.wustl.edu/neuromuscular/nother/paraneo.htm Washington University

    Google Scholar 

  533. www.cancernetwork.com/handbook/emergencies.htm Cancer Network

    Google Scholar 

  534. http://www.lungcanceronline.org/syndromes.htm Lung Cancer Online

    Google Scholar 

  535. http://www.merck.com/pubs/mmanual/section14/chapter177/177e.htm Merck Manual

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology and Oncology, University Medical Center, Hugstetter Strasse 55, 79106, Freiburg, Germany

    Michael Daskalakis, Martin Trepel & Michael Schwabe

  2. Department of Radiation Therapy, University Medical Center, Hugstetter Strasse 55, 79106, Freiburg, Germany

    Karl Henne

  3. Comprehensive Cancer Center Freiburg, Tumorzentrum Ludwig Heilmeyer, Hugstetter Strasse 55, 79106, Freiburg, Germany

    Hartmut Henß

  4. Department of Hematology and Oncology, University Medical Center, Hugstetter Strasse 55, 79106, Freiburg, Germany

    Uwe Martens, Werner Digel, Dietmar P. Berger, Alexandros Spyridonidis & Jürgen Heinz

  5. Department of Hematology and Oncology, University Medical Center, Hugstetter Strasse 55, 79106, Freiburg, Germany

    Rupert Engelhardt, Barbara Deschler & Cornelius Waller

  6. Department of Hematology and Oncology, University Medical Center, Hugstetter Strasse 55, 79106, Freiburg, Germany

    Florian Otto, Hendrik Veelken & Reinhard Marks

  7. Deaconness Hospital, Wirthstrasse 11, 79110, Freiburg, Germany

    H.-P. Allgaier

  8. Department of Gastroenterology, Hepatology, Endocrinology and Infectious Diseases, University Medical Center, Hugstetter Strasse 55, 79106, Freiburg, Germany

    Jan Harder

  9. Hematology, Oncology, Augusta-Kranken-Anstalt, Bergstrasse 26, 44791, Bochum, Germany

    D. Behringer

  10. Department of Gynecology, Jena University Medical Center, Bachstrasse 18, 07743, Jena, Germany

    Ingo Runnebaum

  11. Department of Radiation Therapy, University Medical Center, Hugstetter Strasse 55, 79106, Freiburg, Germany

    Christian Weissenberger

  12. Department of Urology, University Medical Center, Hugstetter Strasse 55, 79106, Freiburg, Germany

    Wolfgang Schultze-Seemann

  13. Department of Nephrology, University Medical Center, Hugstetter Strasse 55, 79106, Freiburg, Germany

    Hartmut Neumann

  14. Medizinische Klinik – Innenstadt, Klinikum der Universität München, Ziemssenstrasse 1, 80336, München, Germany

    Martin Reincke

  15. Department of Gastroenterology Hepatology, Endocrinology and Infectious Diseases, University Medical Center, Hugstetter Strasse 55, 79106, Freiburg, Germany

    Jochen Seufert

  16. Department of Hematology and Oncology, University Medical Center, Hugstetter Strasse 55, 79106, Freiburg, Germany

    Jürgen Finke

Authors
  1. Michael Daskalakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karl Henne
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hartmut Henß
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Uwe Martens
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Werner Digel
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Rupert Engelhardt
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Florian Otto
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Barbara Deschler
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Dietmar P. Berger
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. H.-P. Allgaier
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Jan Harder
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. D. Behringer
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Cornelius Waller
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Martin Trepel
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Ingo Runnebaum
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Christian Weissenberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Alexandros Spyridonidis
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Wolfgang Schultze-Seemann
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. K.G. Schrenk
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. Hartmut Neumann
    View author publications

    You can also search for this author in PubMed Google Scholar

  21. Martin Reincke
    View author publications

    You can also search for this author in PubMed Google Scholar

  22. Jochen Seufert
    View author publications

    You can also search for this author in PubMed Google Scholar

  23. Michael Schwabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  24. Hendrik Veelken
    View author publications

    You can also search for this author in PubMed Google Scholar

  25. Reinhard Marks
    View author publications

    You can also search for this author in PubMed Google Scholar

  26. Jürgen Finke
    View author publications

    You can also search for this author in PubMed Google Scholar

  27. Jürgen Heinz
    View author publications

    You can also search for this author in PubMed Google Scholar

  28. M. Kleber
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Hematology and Oncology, University Medical Center, Hugstetter Str. 55, 79106, Freiburg, Germany

    Dietmar P. Berger , Monika Engelhardt  & Roland Mertelsmann ,  & 

  2. Tumorzentrum Ludwig-Heilmeyer, Comprehensive Cancer Center, University Medical Center, Hugstetter Strasse 55, 79106, Freiburg, Germany

    Hartmut Henß

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Daskalakis, M. et al. (2008). Medical Oncology. In: Berger, D., Engelhardt, M., Henß, H., Mertelsmann, R. (eds) Concise Manual of Hematology and Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-73277-8_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-73277-8_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-73276-1

  • Online ISBN: 978-3-540-73277-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation